European shares gain on earnings boost; Novo Nordisk slips

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

European shares gain on earnings boost; Novo Nordisk slips

- European shares opened higher on Wednesday, as a slew of upbeat corporate earnings lifted sentiment, although gains were capped after heavyweight Novo Nordisk (NYSE:Novo Nordisk dropped 6.6% after the obesity drugmaker posted quarterly operating profit below expectations and also cut its annual profit outlook.

Among other notable moves, car parts maker Continental jumped 5% after it trounced expectations for second-quarter results.Beiersdorf slipped nearly 4% despite the Nivea maker reporting a 7.1% organic sales growth for the first half of the year.

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 450. in İR
 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.

ایران آخرین اخبار, ایران سرفصلها

Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.

Shares of Wegovy maker Novo Nordisk slide 7% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
منبع: CNBC - 🏆 12. / 72 ادامه مطلب »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
منبع: NBCLA - 🏆 319. / 59 ادامه مطلب »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
منبع: CNBC - 🏆 12. / 72 ادامه مطلب »

Lilly, Novo Nordisk Battle for Weight-loss Market Lands At the Pharmacy ShelfAs Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy, some doctors say their guiding principle for writing prescriptions is...
منبع: Medscape - 🏆 386. / 55 ادامه مطلب »